Memory T cells are involved in the downregulation of tumor proliferation rate [76], and DLBCL patients with less than 20% of infiltrating CD4+ cells have an inferior failure-free survival and overall survival [73]. This evidence concerns the gene CD4 and diffuse large B-cell lymphoma.